FDA health claims reg
This article was originally published in The Tan Sheet
Executive Summary
"Disease or health-related condition" definition contained in health claims regulations would be revised under FDA's April 29 proposed rule on dietary supplement structure/function claims. The terms would be changed to "any deviation from, impairment of, or interruption of the normal structure or function of any part, organ, or system (or combination thereof) of the body that is manifested by a characteristic set of one or more signs or symptoms...or a state of health leading to such deviation, impairment, or interruption; except that diseases resulting from essential nutrient deficiencies (e.g., scurvy, pellagra) are not included." The current definition has proven "too narrow" in limiting itself to "serious or long-term diseases and...excluding certain conditions that are medically understood to be diseases, such as headaches," FDA says. Revision also would make the definition consistent with the proposed new definition of "disease" for regulating structure/function claims. Comments are due Aug. 27...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning